AUXILIUM PHARAMCEUTICALS INC
AUXL
AUXL was delisted on the 29th of January, 2015.
150 hedge funds and large institutions have $987M invested in AUXILIUM PHARAMCEUTICALS INC in 2013 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 64 increasing their positions, 45 reducing their positions, and 27 closing their positions.
874% more call options, than puts
Call options by funds: $147M | Put options by funds: $15.1M
42% more repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 45
12% more capital invested
Capital invested by funds: $880M → $987M (+$108M)
4% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 27
1% less funds holding
Funds holding: 152 → 150 (-2)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$31M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$26.2M |
| 3 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$23.7M |
| 4 |
TCP
TAMRO Capital Partners
Alexandria,
Virginia
|
+$17.1M |
| 5 |
FAM
Fred Alger Management
New York
|
+$10.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$42.7M |
| 2 |
Renaissance Technologies
New York
|
-$12.5M |
| 3 |
PWPCM
Perella Weinberg Partners Capital Management
New York
|
-$9.78M |
| 4 |
Millennium Management
New York
|
-$9.7M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$9.44M |
AUXL Hedge Fund Activity: Q3 2013 in Review
150 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in AUXILIUM PHARAMCEUTICALS INC (AUXL) for Q3 2013, worth a combined $987M — up 12% from $880M a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of AUXL and 26 opened new positions — a net loss of 1 holder — while 45 trimmed existing stakes and 64 added.
The largest buyer was Palo Alto Investors, adding an estimated $31M. The largest seller was Deerfield Management, cutting an estimated $42.7M.
- 150 institutional investors held AUXILIUM PHARAMCEUTICALS INC (AUXL) as of Q3 2013, down from 152 in Q2 2013.
- Funds reported $987M of AUXILIUM PHARAMCEUTICALS INC stock for Q3 2013, up 12% quarter-over-quarter.
- 26 funds opened new AUXILIUM PHARAMCEUTICALS INC positions in Q3 2013 and 27 closed out, a net change of -1 holder.
- The largest AUXILIUM PHARAMCEUTICALS INC buyer in Q3 2013 was Palo Alto Investors, an estimated $31M added.
- The largest AUXILIUM PHARAMCEUTICALS INC seller in Q3 2013 was Deerfield Management, an estimated $42.7M sold.
Based on aggregated 13F filings for Q3 2013.